Shandong Xinbo Pharmaceutical R&D

Shandong Xinbo Pharmaceutical Research Co., Ltd. is a prominent Chinese Contract Research Organization (CRO) specializing in preclinical drug safety evaluation and pharmacology. Established in 2010 and headquartered in Dezhou, Shandong, the company provides a wide range of services including toxicology, pharmacokinetics, and medical device evaluation under GLP standards. With nearly 20,000 square meters of laboratory space across sites in Dezhou, Jinan, and Linyi, it holds certifications from the NMPA and is AAALAC accredited. The company has supported the preclinical development of over 500 innovative drugs and 4,800 generic products, covering modalities such as small molecules, biologics, vaccines, and cell therapies. Shandong Xinbo is recognized as a national high-tech enterprise and a Shandong Provincial Gazelle Enterprise, serving a global client base of pharmaceutical companies and research institutions.